X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1628) 1628
Publication (118) 118
Book Review (18) 18
Book Chapter (14) 14
Magazine Article (10) 10
Dissertation (3) 3
Newsletter (2) 2
Paper (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1296) 1296
female (1066) 1066
trichomonas vaginitis - drug therapy (508) 508
trichomonas infections - drug therapy (505) 505
adult (488) 488
male (478) 478
animals (451) 451
index medicus (409) 409
metronidazole - therapeutic use (378) 378
trichomonas vaginalis (288) 288
adolescent (249) 249
infectious diseases (247) 247
middle aged (239) 239
metronidazole (235) 235
trichomonas-vaginalis (219) 219
pregnancy (214) 214
trichomonas vaginalis - drug effects (203) 203
bacterial vaginosis (160) 160
prevalence (157) 157
infections (152) 152
antitrichomonal agents - therapeutic use (150) 150
trichomonas vaginitis - diagnosis (146) 146
women (146) 146
sexually transmitted diseases (139) 139
trichomoniasis (138) 138
candidiasis, vulvovaginal - drug therapy (132) 132
trichomonas vaginalis - isolation & purification (130) 130
trichomonas infections - diagnosis (124) 124
immunology (121) 121
microbiology (121) 121
health aspects (119) 119
anti-bacterial agents - therapeutic use (118) 118
metronidazole - administration & dosage (117) 117
antiprotozoal agents - therapeutic use (116) 116
trichomonas (115) 115
mice (113) 113
diagnosis (112) 112
metronidazole - pharmacology (111) 111
infection (108) 108
drug resistance (101) 101
parasitology (100) 100
sexually transmitted diseases - drug therapy (99) 99
risk factors (93) 93
gonorrhea - drug therapy (88) 88
vaginosis, bacterial - drug therapy (88) 88
drug therapy (87) 87
vaginitis - drug therapy (87) 87
care and treatment (85) 85
obstetrics & gynecology (82) 82
antiprotozoal agents - pharmacology (81) 81
hiv (80) 80
nitroimidazoles - therapeutic use (80) 80
treatment outcome (80) 80
pharmacology & pharmacy (79) 79
vaginitis (79) 79
research (77) 77
trichomonas infections - epidemiology (74) 74
administration, oral (72) 72
sexually transmitted diseases - diagnosis (72) 72
urethritis - drug therapy (72) 72
imidazoles - therapeutic use (70) 70
pregnancy complications, infectious - drug therapy (70) 70
trichomonas vaginitis - epidemiology (70) 70
chlamydia-trachomatis (69) 69
analysis (68) 68
anti-infective agents - therapeutic use (67) 67
medicine, general & internal (67) 67
trichomonas infections - complications (65) 65
research article (64) 64
chlamydia infections - drug therapy (63) 63
risk-factors (63) 63
young adult (63) 63
chlamydia (62) 62
tinidazole - therapeutic use (62) 62
antifungal agents - therapeutic use (60) 60
sexually transmitted diseases - epidemiology (60) 60
trichomonas infections (60) 60
candidiasis, vulvovaginal - diagnosis (59) 59
child (59) 59
chlamydia trachomatis (58) 58
recurrence (57) 57
clinical trials as topic (56) 56
gonorrhea (56) 56
trichomonas vaginitis - complications (56) 56
disease transmission (55) 55
prevention (55) 55
sexually transmitted diseases--std (55) 55
aged (53) 53
trichomonas vaginitis - parasitology (53) 53
urethritis (53) 53
vaginosis, bacterial - diagnosis (53) 53
bacterial infections - drug therapy (52) 52
chemistry, medicinal (51) 51
infant, newborn (51) 51
metronidazole - adverse effects (51) 51
microbial sensitivity tests (51) 51
resistance (51) 51
trichomonas infections - parasitology (51) 51
trichomonas infections - veterinary (51) 51
antitrichomonal agents - pharmacology (50) 50
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1277) 1277
German (109) 109
Russian (106) 106
French (41) 41
Polish (32) 32
Italian (26) 26
Bulgarian (9) 9
Hungarian (8) 8
Spanish (8) 8
Slovak (7) 7
Portuguese (6) 6
Czech (4) 4
Japanese (4) 4
Norwegian (4) 4
Chinese (3) 3
Romanian (3) 3
Ukrainian (3) 3
Danish (2) 2
Swedish (2) 2
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 12/2015, Volume 61, Issue 12, pp. S837 - S848
Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million women and men in the United States.... 
Trichomonas vaginalis | sexually transmitted diseases | Trichomonas infections | antitrichomonal agents | Trichomonas vaginitis | INFECTIOUS DISEASES | LOW-BIRTH-WEIGHT | MICROBIOLOGY | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | AFRICAN-AMERICAN WOMEN | PELVIC-INFLAMMATORY-DISEASE | SEXUALLY-TRANSMITTED INFECTIONS | DELIVERED PARTNER TREATMENT | NEW-YORK-CITY | SINGLE-DOSE TREATMENT | HIV-SERONEGATIVE WOMEN | Sexually Transmitted Diseases - microbiology | Trichomonas Vaginitis - drug therapy | United States - epidemiology | Asymptomatic Infections - epidemiology | Humans | Drug Resistance, Bacterial | Male | Sexually Transmitted Diseases - diagnosis | Sexually Transmitted Diseases - drug therapy | Trichomonas Vaginitis - microbiology | Female | Pregnancy Complications, Infectious - microbiology | Risk Factors | Trichomonas vaginalis - genetics | Evidence-Based Medicine | Centers for Disease Control and Prevention (U.S.) | Pregnancy | Trichomonas Vaginitis - epidemiology | Point-of-Care Systems | HIV Infections - complications | Pregnancy Complications, Infectious - drug therapy | Trichomonas vaginalis - drug effects | HIV Infections - drug therapy | Trichomonas Infections - drug therapy | Antiprotozoal Agents - therapeutic use | Practice Guidelines as Topic | Care and treatment | Usage | Trichomoniasis | Evidence-based medicine | Epidemiology | Analysis | Evidence Papers for the Cdc Sexually Transmitted Diseases Treatment Guidelines
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 1/2011, Volume 52, Issue 2, pp. 163 - 170
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2011, Volume 53, Issue suppl_3, pp. S160 - S172
Trichomonas vaginalis (TV) infection is the most prevalent curable sexually transmitted infection in the United States and worldwide. Most TV infections are... 
Polymerase chain reaction | Urine | Medical treatment failures | Sexually transmitted diseases | HIV | Men | Specimens | Infections | Dosage | Single status | INFECTIOUS DISEASES | RISK-FACTORS | URETHRITIS | RANDOMIZED CLINICAL-TRIAL | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | SEXUALLY-TRANSMITTED INFECTIONS | HIV-NEGATIVE WOMEN | SINGLE-DOSE TREATMENT | METRONIDAZOLE | TINIDAZOLE | Trichomonas vaginalis - pathogenicity | Recurrence | United States - epidemiology | Trichomonas vaginalis - isolation & purification | Humans | Middle Aged | Drug Hypersensitivity | Male | Genital Diseases, Male - epidemiology | Trichomonas Infections - diagnosis | Genital Diseases, Female - parasitology | Mass Screening - methods | Young Adult | Trichomonas Infections - epidemiology | Genital Diseases, Male - drug therapy | Adult | Female | Drug Resistance | Genital Diseases, Male - parasitology | Genital Diseases, Female - epidemiology | Antiprotozoal Agents - adverse effects | Trichomonas Infections - parasitology | Adolescent | HIV Infections - complications | Trichomonas vaginalis - drug effects | Genital Diseases, Female - diagnosis | Trichomonas Infections - drug therapy | Antiprotozoal Agents - therapeutic use | Genital Diseases, Female - drug therapy | Genital Diseases, Male - diagnosis | Practice Guidelines as Topic | Supplement
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 4/2013, Volume 56, Issue 7, pp. 934 - 942
Journal Article
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 09/2009, Volume 116, Issue 10, pp. 1315 - 1324
Introduction  Abnormal vaginal flora (AVF) before 14 gestational weeks is a risk factor for preterm birth (PTB). The presence of aerobic microorganisms and an... 
wet mount microscopy | lactobacillary grades | prematurity | bacterial vaginosis | pregnancy outcome | Aerobic vaginitis | M. hominis | Bacterial vaginosis | Prematurity | Lactobacillary grades | Pregnancy outcome | Wet mount microscopy | LATE MISCARRIAGE | RISK | AMNIOTIC-FLUID | GENITAL-TRACT | DELIVERY | OBSTETRICS & GYNECOLOGY | WOMEN | TRICHOMONAS-VAGINALIS | UREAPLASMA-UREALYTICUM | hominis | ASSOCIATION | LABOR | Ureaplasma Infections - microbiology | Humans | Vaginitis - microbiology | Ureaplasma Infections - drug therapy | Premature Birth - diagnosis | Vaginitis - drug therapy | Mycoplasma hominis - isolation & purification | Pregnancy Trimester, First | Premature Birth - chemically induced | Metronidazole - adverse effects | Adult | Female | Pregnancy Complications, Infectious - microbiology | Parity | Anti-Infective Agents - adverse effects | Ureaplasma urealyticum - isolation & purification | Mycoplasma Infections - microbiology | Risk Factors | Mycoplasma Infections - drug therapy | Vaginosis, Bacterial - drug therapy | Pregnancy | Premature Birth - microbiology | Vaginosis, Bacterial - microbiology | Pregnancy Complications, Infectious - drug therapy | Pregnancy Outcome | Inflammation | Infants (Premature) | Pregnant women | Antidiarrheals | Risk factors | Vaginosis | Microorganisms | Reproductive system | Microbiology | Antibiotics | Premature birth | Index Medicus | Abridged Index Medicus
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 05/2018, Volume 94, Issue 3, pp. 230 - 235
Objectives Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) are curable, mostly asymptomatic, STIs that cause adverse... 
africa | chlamydia trachomatis | neisseria gonorrhoea | trichomonas | pregnancy | INFECTIOUS DISEASES | PREGNANT-WOMEN | TRANSMISSION | SEXUALLY-TRANSMITTED INFECTIONS | Directly Observed Therapy | HIV Infections - prevention & control | Coinfection | Prevalence | Prospective Studies | HIV Infections - epidemiology | Humans | Trichomonas Infections - prevention & control | Young Adult | Anti-Bacterial Agents - therapeutic use | Trichomonas Infections - epidemiology | Pregnancy Complications, Infectious - prevention & control | Pregnant Women | Chlamydia Infections - drug therapy | Adult | Female | Botswana - epidemiology | Gonorrhea - epidemiology | Gonorrhea - prevention & control | Pregnancy Complications, Infectious - epidemiology | Treatment Outcome | Chlamydia Infections - epidemiology | Gonorrhea - drug therapy | Pregnancy | Chlamydia Infections - prevention & control | Pregnancy Complications, Infectious - drug therapy | HIV Infections - drug therapy | Trichomonas Infections - drug therapy | Prenatal Care | Low income groups | Sexually transmitted diseases--STD | Clinics | Premature birth | Diagnostic tests | Systematic review | Infections | Gonorrhea | Obstetrics | Disease control | Prenatal care | Disease prevention | Babies | Hospitals | Chlamydia | Acquired immune deficiency syndrome--AIDS | Newborn babies | Womens health | Medical laboratories | Human immunodeficiency virus--HIV | Syphilis | Condoms | Urogenital system
Journal Article
PLoS One, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0163365
Background This review aimed to synthesize and analyze the diagnostic accuracy and the likelihood of providing correct treatment of the syndromic approach... 
CHLAMYDIAL INFECTIONS | WOMEN | DIAGNOSIS | COST-EFFECTIVENESS | SEXUALLY-TRANSMITTED INFECTIONS | DISEASES | MULTIDISCIPLINARY SCIENCES | PREVALENCE | PRIMARY-HEALTH-CARE | RISK-ASSESSMENT | GONORRHEA | Trichomonas Vaginitis - drug therapy | Risk Assessment | Vaginosis, Bacterial - diagnosis | Humans | Candidiasis - epidemiology | Anti-Infective Agents - therapeutic use | Chlamydia Infections - diagnosis | Vaginal Discharge | Chlamydia Infections - epidemiology | Gonorrhea - drug therapy | Candidiasis - diagnosis | Vaginosis, Bacterial - drug therapy | Trichomonas Vaginitis - epidemiology | Algorithms | Candidiasis - drug therapy | Chlamydia Infections - drug therapy | Female | Gonorrhea - diagnosis | Gonorrhea - epidemiology | Vaginosis, Bacterial - epidemiology | Databases, Factual | Trichomonas Vaginitis - diagnosis | Infection | Vaginal diseases | Care and treatment | Diagnosis | Evidence-based medicine | Infection control | Reproductive health | Sexually transmitted diseases--STD | Systematic review | Infections | Chlamydia trachomatis | Parameter sensitivity | Vaginosis | Confidence intervals | Prostitution | Chlamydia | Risk assessment | Bacteria | Flow charts | Sensitivity analysis | Case management | Vagina | Data processing | Management | Dentistry | Primary care | Discharge | Studies | Sensitivity | Reviews | Microscopy | Womens health | Workers | Diagnostic systems | Quality assessment | Condoms | STD | Sexually transmitted diseases
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 1465 - 9
Utility of syndromic case management (SCM) in women visiting obstetrics & gynecology department needs to be evaluated as it is subjective and imperfect.... 
HOUSE PCR ASSAY | DIAGNOSIS | DISEASES | CHLAMYDIA-TRACHOMATIS | MULTIDISCIPLINARY SCIENCES | NEISSERIA-GONORRHOEAE | PREVALENCE | POINT | Trichomonas Vaginitis - drug therapy | Coinfection | Humans | Middle Aged | Sexually Transmitted Diseases - epidemiology | Sexually Transmitted Diseases - diagnosis | Empirical Research | Anti-Bacterial Agents - therapeutic use | Sexually Transmitted Diseases - drug therapy | Chlamydia Infections - drug therapy | Adult | Female | Gonorrhea - diagnosis | Gonorrhea - epidemiology | Chlamydia trachomatis - drug effects | Vaginosis, Bacterial - epidemiology | Trichomonas Vaginitis - diagnosis | Neisseria gonorrhoeae - drug effects | Office Visits | Vaginosis, Bacterial - diagnosis | Chlamydia Infections - diagnosis | India - epidemiology | Treatment Outcome | Chlamydia Infections - epidemiology | Gonorrhea - drug therapy | Vaginosis, Bacterial - drug therapy | Chlamydia trachomatis - growth & development | Neisseria gonorrhoeae - growth & development | Trichomonas Vaginitis - epidemiology | Hospitals | Case Management | Adolescent | Gardnerella vaginalis - growth & development | Trichomonas vaginalis - drug effects | Trichomonas vaginalis - growth & development | Gardnerella vaginalis - drug effects | Pathogens | Sexually transmitted diseases--STD | Gynecology | Case management | Vagina | Infections | Vaginitis | Obstetrics | Vaginosis | Pain | Ulcers | Antibiotic resistance | Cervicitis
Journal Article